These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7790964)

  • 1. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors.
    Boundy KL; Barnden LR; Rowe CC; Reid M; Kassiou M; Katsifis AG; Lambrecht RM
    J Nucl Med; 1995 Jul; 36(7):1332-8. PubMed ID: 7790964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide.
    Müller-Gärtner HW; Wilson AA; Dannals RF; Wagner HN; Frost JJ
    J Cereb Blood Flow Metab; 1992 Jul; 12(4):562-70. PubMed ID: 1618935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
    Seibyl JP; Wallace E; Smith EO; Stabin M; Baldwin RM; Zoghbi S; Zea-Ponce Y; Gao Y; Zhang WY; Neumeyer JL
    J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo.
    Bakker G; Vingerhoets WA; van Wieringen JP; de Bruin K; Eersels J; de Jong J; Chahid Y; Rutten BP; DuBois S; Watson M; Mogg AJ; Xiao H; Crabtree M; Collier DA; Felder CC; Barth VN; Broad LM; Bloemen OJ; van Amelsvoort TA; Booij J
    J Nucl Med; 2015 Feb; 56(2):317-22. PubMed ID: 25593117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT imaging of dopamine D2 receptors with 2'-iodospiperone.
    Iwasaki Y; Yonekura Y; Saji H; Nishizawa S; Fukuyama H; Iida Y; Magata Y; Shibasaki H; Yokoyama A; Konishi J
    J Nucl Med; 1995 Jul; 36(7):1191-5. PubMed ID: 7790943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123 N-methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors.
    Hicks RJ; Kassiou M; Eu P; Katsifis AG; Garra M; Power J; Najdovski L; Lambrecht RM
    Eur J Nucl Med; 1995 Apr; 22(4):339-45. PubMed ID: 7607265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
    Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
    Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo characterization of 4-[125I]iododexetimide binding to muscarinic cholinergic receptors in the rat heart.
    Matsumura K; Uno Y; Scheffel U; Wilson AA; Dannals RF; Wagner HN
    J Nucl Med; 1991 Jan; 32(1):76-80. PubMed ID: 1988640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy.
    Weckesser M; Hufnagel A; Ziemons K; Griessmeier M; Sonnenberg F; Hackländer T; Langen KJ; Holschbach M; Elger CE; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1156-61. PubMed ID: 9283110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography.
    Boundy KL; Rowe CC; Black AB; Kitchener MI; Barnden LR; Sebben R; Kneebone A; Kassiou M; Katsifis A; Lambrecht R
    Neurology; 1996 Oct; 47(4):1015-20. PubMed ID: 8857738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human biodistribution and internal dosimetry of 4-[
    Pain CD; O'Keefe GJ; Ackermann U; Dore V; Villemagne VL; Rowe CC
    EJNMMI Res; 2020 Jun; 10(1):61. PubMed ID: 32533449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of acetylcholine on binding of 4-[125I]iododexetimide to muscarinic brain receptors.
    Weckesser M; Fixmann A; Holschbach M; Müller-Gärtner HW
    Nucl Med Biol; 1998 Nov; 25(8):777-80. PubMed ID: 9863566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.
    Claus JJ; Dubois EA; Booij J; Habraken J; de Munck JC; van Herk M; Verbeeten B; van Royen EA
    Eur J Nucl Med; 1997 Jun; 24(6):602-8. PubMed ID: 9169565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease.
    Boundy KL; Barnden LR; Katsifis AG; Rowe CC
    J Clin Neurosci; 2005 May; 12(4):421-5. PubMed ID: 15925773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
    Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
    Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased hippocampal muscarinic cholinergic receptor binding measured by 123I-iododexetimide and single-photon emission computed tomography in epilepsy.
    Müller-Gärtner HW; Mayberg HS; Fisher RS; Lesser RP; Wilson AA; Ravert HT; Dannals RF; Wagner HN; Uematsu S; Frost JJ
    Ann Neurol; 1993 Aug; 34(2):235-8. PubMed ID: 8338348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.
    Wilson AA; Dannals RF; Ravert HT; Frost JJ; Wagner HN
    J Med Chem; 1989 May; 32(5):1057-62. PubMed ID: 2785211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenil.
    Dey HM; Seibyl JP; Stubbs JB; Zoghbi SS; Baldwin RM; Smith EO; Zubal IG; Zea-Ponce Y; Olson C; Charney DS
    J Nucl Med; 1994 Mar; 35(3):399-404. PubMed ID: 8113883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
    Drayer B; Jaszczak R; Coleman E; Storni A; Greer K; Petry N; Lischko M; Flanagan S
    J Comput Assist Tomogr; 1982 Jun; 6(3):536-43. PubMed ID: 6980235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.